Bobo Donald E Jr 的 Form 4 申報
Edwards Lifesciences Corp（EW），2022/1/31 申報
- 申報編號
- 0001225208-22-001213
- 申報時間
- 2022/1/31
- 交易日
- 2021/12/22-2022/1/28
- 申報延遲
- 40 天遲報
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 7 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $111.8 萬。交易後 40 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Bobo Donald E JrCIK 0001196661 | 高階主管（CVP,Strategy/Corp Development） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/22 | Common Stock | G贈與取得 | +1,000 | $0.00 | $0 | 57,399.4 | 直接 | |
| 2022/1/28 | Common Stock | M行使選擇權取得 | +11,050 | $21.76 | +$240,448 | 68,449.4 | 直接 | |
| 2022/1/28 | Common Stock | S賣出處分 | −500 | $98.23F3 | −$49,115 | 67,949.4 | 直接 | |
| 2022/1/28 | Common Stock | S賣出處分 | −700 | $99.54F4 | −$69,678 | 67,249.4 | 直接 | |
| 2022/1/28 | Common Stock | S賣出處分 | −2,700 | $101.73F5 | −$274,671 | 64,549.4 | 直接 | |
| 2022/1/28 | Common Stock | S賣出處分 | −3,058 | $102.41F6 | −$313,169.78 | 61,491.4 | 直接 | |
| 2022/1/28 | Common Stock | S賣出處分 | −4,092 | $100.45F7 | −$411,041.4 | 57,399.4 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/1/28 | Common Stock | M行使選擇權處分 | −11,050 | $0.00 | $0 | 33,150 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
This transaction was executed in multiple trades at prices ranging from $97.730 to $98.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $99.070 to $100.000 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $101.340 to $102.190. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $102.340 to $102.655. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This transaction was executed in multiple trades at prices ranging from $100.090 to $100.970. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
備註
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.